Filing Flows › Treace Medical Concepts (TMCI) › Recalls, complaints & regulation
Treace Medical Concepts (TMCI): clinical trials
Treace Medical Concepts (TMCI) beyond its filings: 3 active clinical trials.
Treace Medical Concepts' latest quarter
Treace Medical Concepts, Q3 2026: revenue $48.3M (-4% year over year), operating margin -23.9%, net loss $12.6M, operating cash flow −$3.3M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Treace Medical Concepts have?
3 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.